Independent validation of a prognostic genomic profile (ColoPrint) for stage II colon cancer (CC) patients

被引：2
|
作者：
Rosenberg, R.
Maak, M.
Nitsche, U.
Schuster, T.
Kuenzli, B.
Snel, M.
Simon, I.
Janssen, K.
Friess, H.
机构：
[1] Tech Univ Munich, Klinikum Rechts Isar, Dept Surg, D-80290 Munich, Germany
[2] Tech Univ Munich, Klinikum Rechts Isar, Dept Epidemiol & Stat, D-80290 Munich, Germany
[3] Agendia BV, Amsterdam, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.3513
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3513
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [21] The impact of adjuvant chemotherapy regimens in stage II colon cancer (CC) patients
    Lobo-Martins, S.
    Martins, M.
    Semedo, P.
    Alvim, C.
    Luna Pais, H.
    Paiva, R.
    Pinto, C.
    Ribeiro, L.
    Fernandes, I.
    Macedo, D.
    Mansinho, A.
    Vendrell, I.
    Teixeira de Sousa, R.
    Costa, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S139 - S139
  • [22] Establishment and validation of a prognostic nomogram for patients with early-onset stage I–II colon cancer
    Dongdong Li
    World Journal of Surgical Oncology, 21
  • [23] Development and validation of a prognostic nomogram for patients with stage II colon mucinous adenocarcinoma
    Huang, Jia
    Zhang, Yiwei
    Zhou, Jia
    Fang, Min
    Wu, Xiaofeng
    Luo, Yuhang
    Huang, Qiulin
    Ouyang, Yujuan
    Xiao, Shuai
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022, 37 (10) : 2173 - 2184
  • [24] Development and validation of a prognostic nomogram for patients with stage II colon mucinous adenocarcinoma
    Jia Huang
    Yiwei Zhang
    Jia Zhou
    Min Fang
    Xiaofeng Wu
    Yuhang Luo
    Qiulin Huang
    Yujuan Ouyang
    Shuai Xiao
    International Journal of Colorectal Disease, 2022, 37 : 2173 - 2184
  • [25] The PARSC trial, a prospective study for the assessment of recurrence risk in stage II colon cancer patients using ColoPrint.
    Salazar, Ramon
    Marshall, John
    Capdevila, Jaume
    Glimelius, Bengt
    de Waard, Jan Willem
    Van Der Hoeven, Jacobus
    Klaase, Joost
    Bibeau, Frederic
    Bachleitner-Hofmann, Thomas
    Midgley, Rachel A.
    Levine, Edward Allen
    Law, Wai Lun
    Asano, Michio
    Chang, George J.
    Cohen, Stephen M.
    Beart, Robert W.
    Goldfarb, Paul M.
    McCarter, Martin
    Stork-Sloots, Lisette
    Rosenberg, Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [26] Validation of a 12-gene colon cancer recurrence score (RS) in patients (pts) with stage II colon cancer (CC) from CALGB 9581
    Venook, A. P.
    Niedzwiecki, D.
    Lopatin, M.
    Lee, M.
    Friedman, P. N.
    Frankel, W.
    Clark-Langone, K.
    Yoshizawa, C.
    Millward, C.
    Shak, S.
    Goldberg, R. M.
    Mahmoud, N. N.
    Schilsky, R. L.
    Bertagnolli, M. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [27] Genomic Classifier ColoPrint Predicts Recurrence in Stage II Colorectal Cancer Patients More Accurately Than Clinical Factors
    Kopetz, Scott
    Tabernero, Josep
    Rosenberg, Robert
    Jiang, Zhi-Qin
    Moreno, Victor
    Bachleitner-Hofmann, Thomas
    Lanza, Giovanni
    Stork-Sloots, Lisette
    Maru, Dipen
    Simon, Iris
    Capella, Gabriel
    Salazar, Ramon
    ONCOLOGIST, 2015, 20 (02): : 127 - 133
  • [28] Hypoxia-Driven Gene Expression Is an Independent Prognostic Factor in Stage II and III Colon Cancer Patients
    Dekervel, Jeroen
    Hompes, Daphne
    van Malenstein, Hannah
    Popovic, Dusan
    Sagaert, Xavier
    De Moor, Bart
    Van Cutsem, Eric
    D'Hoore, Andr E.
    Verslype, Chris
    van Pelt, Jos
    CLINICAL CANCER RESEARCH, 2014, 20 (08) : 2159 - 2168
  • [29] Establishment and validation of a prognostic nomogram for patients with early-onset stage I-II colon cancer
    Li, Dongdong
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [30] Adjuvant chemotherapy (ACT) in stage II colon cancer (CC) in patients with Lynch syndrome
    Schulmann, Karsten
    Koepnick, Sven
    Engel, Christoph
    Bernhardt, Christiane
    Steinke, Verena
    Royer-Pokora, Brigitte
    Schackert, Hans K.
    Doeberitz, Magnus von Knebel
    Holinski-Feder, Elke
    Buettner, Reinhard
    Schmiegel, Wolff H.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345